Transoesophageal Doppler cardiac output measurement was evaluated against the thermodilution method in eleven patients undergoing elective cardiac surgery. A total of 106 pairs of Doppler and thermodilution values were obtained. Cardiac output was measured over a range of 2.3 l.min-I to 11.5 l.min-I. The mean difference between the Doppler and thermodilution measures was -1.0 l.min-I (thermodilution minus Doppler). Standard deviction was 1.8 l.min-I. This is a significant difference. It is concluded that these techniques do not agree when measuring cardiac outputs.
Intraoperative monitoring of cardiac output is frequently performed by the employment of the thermodilution technique. This requires the insertion of a pulmonary artery catheter with all its attendant invasive riskS. I ,2 The Lawrence 3000 Cardiac Output Monitor is a noninvasive device which employs continuous wave Doppler ultrasound to measure cardiac output. The purpose of this study was to assess the Lawrence 3000's agreement with thermodilution in measuring cardiac output in patients undergoing elective cardiac surgery.
MATERIALS AND METHODS Patients were eligible to be studied if they were undergoing elective cardiac surgery and required the insertion of a pulmonary artery catheter as part of their management. Patients with aortic valve lesions were excluded because the Doppler technique requires laminar aortic flow. 3 ,4 Patients with arrhythmias were excluded if the arrhythmia precluded a steady state of stroke volume, to ensure correct comparison between the Doppler beat-tobeat method and the thermodilution averaging method. 5 After intravenous induction and tracheal intubation, an anaesthetist passed the oesophageal probe per orem to a distance of 40-45 cm from the incisors (Figure 1 ). A white line along the length of the probe ensured correct crystal orientation in the coronal plane. The crystal had been coated with ultrasound gel to improve its acoustic coupling prior to its passage.
A pulmonary artery catheter was inserted (Baxter 93A-831H-7.5F) and was verified as being correctly placed by the sequential observation of central venous, right ventricular and pulmonary artery (wedged and unwedged) pressures and waveforms. The oesophageal probe was then positioned by rotation and/or withdrawal to receive maximal reflection and record an ejection time consistent with the ejection time of the descending aorta (as deemed by the Lawrence manual). The probe was then secured.
The suprasternal probe was coated with gel and beamed at the ascending aorta. Correct aiming was determined by reference to the ejection time and signal strength and the Doppler sound. Each patient's height, weight, sex and age had already been entered into the monitor. The monitor calculated cardiac output from the suprasternal probe signal and a nomogram for ascending aortic diameter. The monitor displayed suprasternally measured cardiac output values, and indicated whether they were 'high' or 'low' for each patient's anthropometric data, affording additional information to assist in aiming the probe. Once aiming was complete, a calibration button was pressed and the suprasternal probe removed. The monitor thereafter relied on the oesophageal probe signal to calculate cardiac output.
Cardiac output was measured using the thermodilution technique by the rapid manual injection of a 10 ml bolus at end-expiration via the central venous pressure lumen. An in-line and a distal thermistor probe measured injectate and pulmonary artery temperatures respectively. Calculation of cardiac output was performed using the cardiac output cartridge of the Siemens Sirecust 404-1 Monitor and according to the Siemens Manual. Injectate was at room temperature apart from one patient where iced injectate and an offline thermistor were used.
Two to three paired measurements of cardiac output were made simultaneously by the Doppler and thermodilution techniques at steady haemodynamic states as judged by a regular ECG and radial artery pressure trace and little Doppler display beat-by-beat variability. Measurements occurred before and just after the chest was opened, and just after the chest was closed. Measurements were also recorded whenever cardiac output changed by more than 10% in the normal course of anaesthesia and surgery (as indicated by the Doppler display) and had achieved a new steady state. In this way within each patient a range of cardiac outputs was measured. Measurements were not recorded during periods of diathermy, surgical movement or bypass because these can lead to errors in the measurement of cardiac output using either technique (see discussion).
Statistical analysis was performed by the method of comparisons as described by Bland and Altman. 6 ,7 
RESULTS
Eleven patients were included in the study. In total 106 pairs of thermodilution and Doppler values were obtained for analysis. These paired values were plotted in Figure 2 . The mean cardiac output for each technique was calculated for each patient's data and for the pooled data ( Table 1) . The difference between the mean Doppler and thermodilution values of cardiac output was also calculated for each patient's data and for the pooled data (Table 1) as thermodilution minus Doppler. Figure 3 plots the difference between each technique against the mean of both techniques for each paired reading. The mean difference calculated from the pooled data was -1.0 l.min-1 and standard deviation 1.8 l.min-l. The data was analysed using Student's paired t-test and the pooled difference was found to be significant (P<O.OOI). .. The potential inaccuracies of the thermodilution technique are well known and have been reviewed elsewhere. 8 -IO The potential inaccuracies of the Doppler technique will now be considered..
The Lawrence 3000 Monitor calculates erythrocyte velocity by the formula: 1l ,12 Velocity = df x c 2fo x cos ' I> where df = the difference in frequency between the incident and reflected beam, c = the speed of sound in blood, fo = the incident frequency and ' I> = the angle of incidence.
The principle source of error in calculating velocity is cos ' 1>. Provided the angle of incidence of the suprasternal probe is less than fifteen degrees !his error is minimal. 5 ,12-15 The oesophageal probe IS angled at 45 degrees to the descending aorta. At Aiming the probes is made difficult because the velocity analogue signal is not displayed. 16 This velocity 'envelope' was used by many workers 14 ,15,17-19 to ensure that they had targeted the correct vessel. Difficulties can also arise with suprasternal aiming when the anatomy is distorted in patients with congenital lesions, tortuous aorta, COAD, obesity and previous neck and mediastinal surgery, 12, 15, 17, 18 and in some paediatric subjects due to 'ventilation ... artifacts'P The Monitor calculates stroke volume and cross sectional area according to the following equations: The monitor calculates cross sectional area as: Cross sectional area = 1t (diameter12)2
An error in measuring the diameter can lead to a relatively large error in the value for area. 14 ,17,19,21,22 Freund employed a nomogram to determine diameter but this is not without problems. 23 The diameter can also be measured by echocardiography. 12, 15, 19, 21, 24 Sources of error using this technique include variations of posture, 18 cardiac cycle,II. 13, 15, 19, 22, 24 and aortic root pressure. 21 There is also disagreement about the echocardiographic definition of diameter l3 -15,17,19,21 and the assumption of a circular aorta. II- 13, 18, 19 The Lawrence 3000 samples velocity from a small portion of the vesseP4,24 and extends that velocity across the vessel's entire cross section. It assumes that blood flow is laminar with a flat profile 13 ,14,24,25 and that the boundary/motionless layer is small. l1 ,15 This appears to be true in the aortic root 16 ,26 and in the ascending aorta. 12 -14 However, Bernstein considers that the velocity profile in the normal ascending aorta is skewed and not flat 19 ,27 and Tibballs 16 states that descending aortic flow profile is parabolic.
Another source of error is ensuring that the measured velocity and diameter are at the same place. 12 ,19,21,24 Tibballs et af.1 5 ,16 notes that as continuous wave Doppler measures velocity along the entire beam path, 'vessels other than aorta may be insonated. '16 Others also refer to this problem. 12, 13, 17, 19, 27 Pulsed as opposed to continuous wave Dopplers can be range-gated 21 to measure velocity at a set distance from the probe. 14 This assists in ensuring co-locality of velocity and diameter measurements. 2-D echo imaging may also help13 and may simultaneously specify sampling site and incidence angle. 13,21 A disadvantage of pulsed Doppler is that if the range velocity product of the instrument is exceeded then inaccuracies may arise in the velocity profile 12 such as (theoretical) aliasing. 19 Measuring cardiac output at the level of the ascending aorta is inaccurate because it excludes coronary artery flOW l1 ,14 (although Donovan et at. point out that most of this flow is during diastole. 19) Rein et at. explain that shunts at great artery level may invalidate aortic measures of cardiac output. 14, 17 In some cases no Doppler values were produced after bypass. This may be related to the nonpulsatile flow of cardiopulmonary bypass. Recalibration may be impossible due to mediastinal air or lack of suprasternal access. Surgical handling of the thoracic viscera may displace the oesophageal probe. 28 -3o Oesophageal monitoring assumes a fixed relationship between ascending and descending aortic blood flow. 3 ,16 Cooling and warming related to bypass may alter regional perfusion and this relationship. A postbypass fall in haematocrit could lead to a weaker reflected signal which could impair the accuracy of the velocity integral calculated. 13 The clinical significance of these effects of bypass is crucial if the monitor is to serve as an alternative to thermodilution in cardiac anaesthesia.
Finally, with any new monitor, refinement of the equipment and operator expertise will improve clinical performance. For example, provision of a velocity analogue signal would aid probe aiming and minimise clinical error. A means of ensuring greater locational stability and orientation of the oesophageal probe and a countering of possible calibration drift would be beneficial. Duplex probes would be ideal. In its present form the Lawrence 3000 monitor may be better suited to other clinical settings. Non-thoracic surgery would permit frequent recalibration and would also minimise surgical displacement of the oesophageal probe. CONCLUSION This study was unable to prove that the Lawrence 3000 Monitor agreed with thermodilution measurements when employed in clinical intraoperative conditions by nonechocardiographers. The extent of disagreement over a range of measured cardiac outputs averaged -1.0 I.min-1 (thermodilution minus Doppler). This figure is too great to support its widespread clinical introduction. This view is consistent with that of Siegel et al. 31 and Fagard et al. 21 The Doppler technique is made attractive by its noninvasive nature and speed and ease of use. It is hoped that further clinical experience and monitor development will permit validation of its clinical use.
